Molecular Aspects of Cancer Treatment and of Cancer Risk
Presented by AACR-Minorities in Cancer Research (MICR)
Tuesday, April 17, 2007
10:00 a.m. - 12:00 p.m.
Room 301 A-B, Los Angeles Convention Center
Description:
This session will address whether it might be reasonable to ask the scientific question: Are there molecular processes that traffic with race/ethnicity, that may contribute to disparities in cancer outcomes?
Co-Chairpersons:
Eddie Reed, Centers for Disease Control and Prevention, Atlanta, GA
Jean G. Ford, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
Moderator:
Jean G. Ford, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
Speakers:
Molecular biology of CYP polymorphisms and cancer risk
Beverly D. Lyn-Cook, FDA-NCTR, Jefferson, AR
Molecular biology of treatment of hemoglobinopathies
Griffin P. Rodgers, NIDDK, Bethesda, MD
Translational Oncogenomics
John D. Carpten, TGen, Phoenix, AZ
Molecular aspects of therapy resistance in advanced prostate cancer
Carlos A. Casiano, Loma Linda University, Loma Linda, CA